Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB

Tim3表达和Tim3 T细胞在结核病中的免疫功能及机制

基本信息

  • 批准号:
    8892993
  • 负责人:
  • 金额:
    $ 20万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-15 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): While T cells play a role in host defense against Mycobacterium tuberculosis (Mtb) infection, over-reacting T cell responses may contribute to tuberculosis (TB) inflammation and lesions. It is, therefore, important to characterize immune regulation and function of T cell responses in TB. T cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) is a membrane protein initially identified as a negative regulator of Th1 cells. However, new studies suggest that Tim-3 expression/ functions in infections appear to be more diverse than previously thought. We have recently found that active TB in macaques and humans remarkably up- regulated Tim-3 expression and that Tim-3+ CD4+/CD8+ T cells displayed polarized effector memory phenotypes. Tim-3+ CD4+/CD8+ T cell subsets showed greater effector functions for producing Th1/Th22/CTL cytokines and for inhibiting intracellular Mtb than Tim-3- T cells. Tim-3+ CD4+/CD8+ T cell subsets are more activated as they expressed much higher levels of phosphorylated signaling molecules p38, stat3, stat5, and Erk1/2 than Tim-3- controls. Silencing of Tim-3 pathway reduced T cell effector function in TB, and stimulation of Tim-3 augmented T effector functions. Our novel findings implicate a new paradigm that Tim-3 signaling facilitates stronger effector functions in active TB patients. We also found that PD-1+ and PD-1- T cells expressed distinct miRNA signatures, and down-regulation of human miRNA miR-31 in PD-1+ T cells enforces stronger effector functions during active TB. Since large numbers of CD4+ and CD8+ T cells express Tim-3 in infections, it is critical to determine whether Tim-3+ CD4+/CD8+ T cells are protective or detrimental, and functional mechanisms. We hypothesize that selected miRNAs help to control or regulate effector functions of Tim-3+ CD4+ and CD8+ T cells in human TB or HIV+TB, and that Tim-3+ T cell effector cells may have double-edge function contributing to both anti-TB immunity and over-reactive immune pathology for TB inflammation and lesions. Our specific aims are: Aim I. Determine if selected miRNAs in Tim-3+ T cells control or regulate effector functions of Tim- 3+ CD4+/CD8+ T cells in active human TB. Aim II. Investigate if selected miRNA signatures in HIV-1 infection potentially depress anti-TB effector functions of Tim-3+ CD4+/CD8+ T cells in HIV+ TB. Aim III. Examine if r-galectin-9 administration during chronic TB can reduce or deplete Tim-3+ CD4+/CD8+ T cells and attenuate immunopathology and TB lesions in macaques. Aim IV. Determine if rapid increases in Tim-3+ T effector cells by adoptive transferring of Tim-3+ T cells during early Mtb infection can confer immune protection against TB in macaques.
描述(申请人提供):虽然T细胞在抵抗结核分枝杆菌(Mtb)感染的宿主防御中发挥作用,但过度反应的T细胞反应可能导致结核病(TB)炎症和病变。因此,重要的是要确定结核病的免疫调节和T细胞反应的功能。T细胞免疫球蛋白和粘蛋白结构域包含分子3(Tim-3)是一种膜蛋白,最初被认为是一种负调控因子。 Th1细胞。然而,新的研究表明,TIM-3在感染中的表达/功能似乎比之前认为的更加多样化。我们最近发现,在猕猴和人类中,活动性结核显著上调了TIM-3的表达,并且TIM-3+CD4+/CD8+T细胞表现出极化的效应记忆表型。与TIM-3-T细胞相比,TIM-3+CD4+/CD8+T细胞亚群在产生Th1/Th22/CTL细胞因子和抑制细胞内Mtb方面具有更强的效应功能。TIM-3+CD4+/CD8+T细胞亚群比TIM-3-对照组表达更高水平的磷酸化信号分子p38、STAT3、STAT5和ERK1/2。TIM-3途径的沉默降低了TB的T细胞效应功能,而刺激TIM-3则增强了T细胞效应功能。我们的新发现暗示了一种新的范式,即TIM-3信号促进了活动性结核病患者更强的效应器功能。我们还发现PD-1+和PD-1-T细胞表达不同的miRNA信号,而PD-1+T细胞中人miRNA miR-31的下调增强了活动性TB的效应功能。由于感染时大量的CD4+和CD8+T细胞表达Tim-3,因此确定Tim-3+CD4+/CD8+T细胞是保护性的还是有害的及其作用机制至关重要。我们推测,我们选择的miRNAs有助于控制或调节人类TB或HIV+TB中Tim-3+CD4+和CD8+T细胞的效应功能,并且Tim-3+T细胞效应细胞可能具有参与抗TB免疫和TB炎症和病变的过度反应免疫病理的双刃性功能。我们的具体目标是:目标1.确定TIM-3+T细胞中选定的miRNAs是否控制或调节活动期人类结核病患者TIM-3+CD4+/CD8+T细胞的效应功能。目的II.研究HIV-1感染中特定的miRNA信号是否可能抑制HIV+TB患者Tim-3+CD4+/CD8+T细胞的抗结核效应功能。目的III.检测慢性肺结核期间应用r-Galectin-9是否能减少或耗尽TIM-3+CD4+/CD8+T细胞,减轻免疫病理和结核病病变。目的:确定在结核分枝杆菌感染早期通过过继转移TIM-3+T细胞快速增加的TIM-3+T效应细胞是否具有免疫保护作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zheng W Chen其他文献

The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection
Th17 相关细胞因子/信号通路在结核分枝杆菌感染中的关键作用
  • DOI:
    10.1038/cmi.2017.128
  • 发表时间:
    2017-11-27
  • 期刊:
  • 影响因子:
    19.800
  • 作者:
    Hongbo Shen;Zheng W Chen
  • 通讯作者:
    Zheng W Chen

Zheng W Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zheng W Chen', 18)}}的其他基金

Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
Ag 特异性 γ δ T 细胞和对结核病/艾滋病相关结核病的免疫力
  • 批准号:
    8670046
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
Ag 特异性 γ δ T 细胞和对结核病/艾滋病相关结核病的免疫力
  • 批准号:
    8501805
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB
Tim3表达和Tim3 T细胞在结核病中的免疫功能及机制
  • 批准号:
    8721335
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
Ag 特异性 γ δ T 细胞和对结核病/艾滋病相关结核病的免疫力
  • 批准号:
    8846156
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
6th International gamma delta T-cell conference
第六届国际γδT细胞会议
  • 批准号:
    8652003
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Immune function and mechanism of Tim3 expression and Tim3+ T cells in TB & HIV+TB
Tim3表达和Tim3 T细胞在结核病中的免疫功能及机制
  • 批准号:
    8546669
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
GAMMA DELTA T CELLS AND TUBERCULOSIS
GAMMA Delta T 细胞与结核病
  • 批准号:
    7958662
  • 财政年份:
    2009
  • 资助金额:
    $ 20万
  • 项目类别:
GAMMA DELTA T CELLS AND TUBERCULOSIS
GAMMA Delta T 细胞与结核病
  • 批准号:
    7716314
  • 财政年份:
    2008
  • 资助金额:
    $ 20万
  • 项目类别:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
炭疽、鼠疫和兔热病的免疫治疗和疫苗
  • 批准号:
    7653679
  • 财政年份:
    2006
  • 资助金额:
    $ 20万
  • 项目类别:
Immunotherapeutics and vaccines against anthrax, plague and tularemia
炭疽、鼠疫和兔热病的免疫治疗和疫苗
  • 批准号:
    7919995
  • 财政年份:
    2006
  • 资助金额:
    $ 20万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了